ATE292110T1 - Herstellungsverfahren von arylethanolaminderivate zur behandlung von diabetes und fettleibigkeit - Google Patents
Herstellungsverfahren von arylethanolaminderivate zur behandlung von diabetes und fettleibigkeitInfo
- Publication number
- ATE292110T1 ATE292110T1 AT00985495T AT00985495T ATE292110T1 AT E292110 T1 ATE292110 T1 AT E292110T1 AT 00985495 T AT00985495 T AT 00985495T AT 00985495 T AT00985495 T AT 00985495T AT E292110 T1 ATE292110 T1 AT E292110T1
- Authority
- AT
- Austria
- Prior art keywords
- obesity
- diabetes
- treatment
- production process
- arylethanolamine derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
- C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/52—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
- C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Child & Adolescent Psychology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Glass Compositions (AREA)
- Iron Core Of Rotating Electric Machines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9929297.1A GB9929297D0 (en) | 1999-12-11 | 1999-12-11 | Process |
| PCT/GB2000/004697 WO2001042195A1 (en) | 1999-12-11 | 2000-12-08 | Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE292110T1 true ATE292110T1 (de) | 2005-04-15 |
Family
ID=10866125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT00985495T ATE292110T1 (de) | 1999-12-11 | 2000-12-08 | Herstellungsverfahren von arylethanolaminderivate zur behandlung von diabetes und fettleibigkeit |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US6548523B2 (de) |
| EP (1) | EP1235788B1 (de) |
| JP (1) | JP4903964B2 (de) |
| KR (1) | KR100683614B1 (de) |
| CN (1) | CN1224609C (de) |
| AT (1) | ATE292110T1 (de) |
| AU (1) | AU769387B2 (de) |
| BR (1) | BRPI0016187B1 (de) |
| CA (1) | CA2394117C (de) |
| CZ (1) | CZ303143B6 (de) |
| DE (1) | DE60019157T2 (de) |
| ES (1) | ES2236020T3 (de) |
| GB (1) | GB9929297D0 (de) |
| HK (1) | HK1045988B (de) |
| HU (1) | HU229043B1 (de) |
| IL (1) | IL149585A0 (de) |
| NO (1) | NO323239B1 (de) |
| NZ (1) | NZ518795A (de) |
| PL (1) | PL200540B1 (de) |
| PT (1) | PT1235788E (de) |
| TR (1) | TR200201528T2 (de) |
| WO (1) | WO2001042195A1 (de) |
| ZA (1) | ZA200204585B (de) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10230147A1 (de) * | 2001-10-09 | 2004-01-15 | Profos Ag | Verfahren zur unspezifischen Anreicherung von Bakterienzellen |
| US7158049B2 (en) * | 2003-03-24 | 2007-01-02 | Schlumberger Technology Corporation | Wireless communication circuit |
| US8213085B2 (en) * | 2008-01-18 | 2012-07-03 | Visera Technologies Company Limited | Image sensor device with high photosensitivity |
| US8778998B2 (en) * | 2009-04-10 | 2014-07-15 | Auspex Pharmaceuticals, Inc. | Biphenyl-3-carboxylic acid modulators of beta-3-adrenoreceptor |
| KR20130135239A (ko) | 2010-08-03 | 2013-12-10 | 앨씨알엑스, 인크. | 과민성 방광 치료를 위한 베타-3 아드레날린 수용체 작용제 및 무스카린 수용체 길항제의 약학적 배합제 |
| US9907767B2 (en) | 2010-08-03 | 2018-03-06 | Velicept Therapeutics, Inc. | Pharmaceutical compositions and the treatment of overactive bladder |
| TW201338772A (zh) | 2012-02-09 | 2013-10-01 | Altherx Inc | 藥學組合物 |
| US9956194B2 (en) | 2014-12-03 | 2018-05-01 | Velicept Therapeutics, Inc. | Compositions and methods of using modified release solabegron for lower urinary tract symptoms |
| PT3365321T (pt) | 2015-10-23 | 2024-01-12 | B3Ar Therapeutics Inc | Zwiterião de solabegron e suas utilizações |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1551260A (en) * | 1976-02-09 | 1979-08-30 | Allen & Hanburys Ltd | Phenylethanolamine derivatives |
| JP2577222B2 (ja) * | 1987-04-10 | 1997-01-29 | 興和株式会社 | 新規な置換アニリド誘導体 |
| NO179246C (no) * | 1991-11-20 | 1996-09-04 | Sankyo Co | Aromatiske amino-alkoholderivater og mellomprodukter til fremstilling derav |
| GB9525121D0 (en) * | 1995-12-08 | 1996-02-07 | Glaxo Group Ltd | Chemical compounds |
| WO1999057098A2 (en) * | 1998-05-01 | 1999-11-11 | Abbott Laboratories | Substituted beta-amino acid inhibitors of methionine aminopeptidase-2 |
| GB9812709D0 (en) * | 1998-06-13 | 1998-08-12 | Glaxo Group Ltd | Chemical compounds |
-
1999
- 1999-12-11 GB GBGB9929297.1A patent/GB9929297D0/en not_active Ceased
-
2000
- 2000-12-08 EP EP00985495A patent/EP1235788B1/de not_active Expired - Lifetime
- 2000-12-08 NZ NZ518795A patent/NZ518795A/en unknown
- 2000-12-08 DE DE60019157T patent/DE60019157T2/de not_active Expired - Lifetime
- 2000-12-08 US US10/148,841 patent/US6548523B2/en not_active Expired - Lifetime
- 2000-12-08 PL PL356483A patent/PL200540B1/pl unknown
- 2000-12-08 AU AU21911/01A patent/AU769387B2/en not_active Ceased
- 2000-12-08 CZ CZ20022017A patent/CZ303143B6/cs not_active IP Right Cessation
- 2000-12-08 HU HU0203640A patent/HU229043B1/hu not_active IP Right Cessation
- 2000-12-08 BR BRPI0016187A patent/BRPI0016187B1/pt not_active IP Right Cessation
- 2000-12-08 PT PT00985495T patent/PT1235788E/pt unknown
- 2000-12-08 WO PCT/GB2000/004697 patent/WO2001042195A1/en active IP Right Grant
- 2000-12-08 IL IL14958500A patent/IL149585A0/xx not_active IP Right Cessation
- 2000-12-08 CA CA2394117A patent/CA2394117C/en not_active Expired - Fee Related
- 2000-12-08 TR TR2002/01528T patent/TR200201528T2/xx unknown
- 2000-12-08 ES ES00985495T patent/ES2236020T3/es not_active Expired - Lifetime
- 2000-12-08 KR KR1020027007383A patent/KR100683614B1/ko not_active IP Right Cessation
- 2000-12-08 AT AT00985495T patent/ATE292110T1/de active
- 2000-12-08 JP JP2001543497A patent/JP4903964B2/ja not_active Expired - Fee Related
- 2000-12-08 CN CNB008170177A patent/CN1224609C/zh not_active Expired - Fee Related
-
2002
- 2002-06-07 ZA ZA200204585A patent/ZA200204585B/xx unknown
- 2002-06-10 NO NO20022758A patent/NO323239B1/no not_active IP Right Cessation
- 2002-10-16 HK HK02107499.9A patent/HK1045988B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE446758T1 (de) | Verwendung von wachstumshormonsekretagoga zur förderung der beweglichkeit des verdauungstrakts | |
| ATE361287T1 (de) | Neue indol-2-on derivate | |
| DE60112942D1 (de) | Verbindungen zur behandlung der alzheimerischen krankheit | |
| YU29502A (sh) | Proces dobijanja 4"-supstituisanog 9-dezokso-9a-aza-9a derivata homoeritromicina a | |
| ATE272398T1 (de) | Verwendung von ep4 rezeptorliganden zur behandlung von neuropathischen schmerz | |
| MY136686A (en) | Salt forms of 3-(4-bromo-2,6-difluoro-benzyloxy)-5-[3-(4-pyrrolidin-1-yl-butyl)-ureido]-isothiazole-4-carboxylic acid amide and method of production | |
| ATE367387T1 (de) | Verwendung von oxindolderivaten zur behandlung von mit demenz in zusammenhang stehenden krankheiten, alzheimer-krankheit und mit glycogensynthasekinase-3 assoziierten leiden | |
| ATE292110T1 (de) | Herstellungsverfahren von arylethanolaminderivate zur behandlung von diabetes und fettleibigkeit | |
| DE60103978D1 (de) | Prodigiosin-derivate zur bekämpfung von krebs und virus-bedingten krankheiten | |
| HUP0002170A2 (hu) | Egy specifikus 5HT2 receptor antagonista alkalmazása alvás közben fellépő apnoe szindróma kezelésére szolgáló gyógyszerkészítmény előállítására | |
| HK1075894A1 (en) | Prucalopride-n-oxide | |
| ATE369858T1 (de) | Eisenchelatoren und arzneimittel enthaltend eisenchelatoren zur behandlung von neurodegenerativen erkrankungen | |
| HUP0301594A2 (hu) | E-metanikotin diacilborkősav sóját tartalmazó gyógyászati készítmények és alkalmazásuk a központi idegrendszer rendellenességeinek kezelésére | |
| PT1218401E (pt) | 4-benzilaminoquinolinas conjugadas com acido biliar e seus heterociclicos metodos de sua producao medicamentos contendo estes compostos e sua aplicacao | |
| WO2002058680A3 (en) | Use of bicylic amino acids for preventing and treating visceral pain and gastrointestinal disorders | |
| CY1107037T1 (el) | Χρηση ακετυλ l-καρνιτινης για την παρασκευη ενος φαρμακου για την προληπτικη αγωγη του μετεγχειρητικου πονου | |
| ATE212842T1 (de) | Quinoxalin-derivate zur behandlung von tinnitus | |
| DE60315597D1 (de) | Haloacetamidobenzoesäure derivate und deren verwendung zur behandlung von parasitären erkrankungen | |
| DE69902142T2 (de) | Azetidincarboxamidderivate zur behandlung von zns-erkrankungen | |
| DE60108775T8 (de) | Methode zur behandlung von schlaganfall | |
| ATE301997T1 (de) | Antivirale therapie | |
| MXPA06000995A (es) | Amidas novedosas de acido indolil-3-glioxilico sustituidas en el atomo de n, uso de las mismas como medicamento y metodo para la produccion de las mismas. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1235788 Country of ref document: EP |